Transforming growth factor-β differentially inhibits epithelial ovarian carcinoma cells from primary and metastatic isolates without up-regulation of p21(WAF1)

Cancer

Volumn 85, Issue 8, 1999, Pages 1810-1815

  Hurteau, Jean A ^a   Allison, Bernadette ^a   Sutlon, Gregory P ^a   Moore, David H ^a   Look, Katherine Y ^a   Hurd, William ^b   Bigsby, Robert M ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Metastasis; Ovarian carcinoma; P21(WAF1); Primary tumor; Transforming growth factor

Indexed keywords

PROTEIN P21; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL ISOLATION; CLINICAL ARTICLE; DOSE RESPONSE; DRUG MECHANISM; EPITHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; METASTASIS; NORTHERN BLOTTING; OVARY CARCINOMA; PRIORITY JOURNAL;

CARCINOMA; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; RNA, MESSENGER; RNA, NEOPLASM; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0033561011     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990415)85:8<1810::AID-CNCR22>3.0.CO;2-E     Document Type: Article

References (22)

1. Roberts AB, Sporn MB. The transforming growth factor-betas. In: Sporn MB, Roberts AB, editors. Peptide growth factors and their receptors I. Berlin: Springer-Verlag, 1990: 419-72.
2. Barnard JA, Lyons RM, Moses HL. The cell biology of transforming growth factor-β. Biochim Biophys Acta 1990;1032: 79-87.
3. Massague J. Receptors for the TGF-β family. Cell 1992;69: 1067-70.
4. Moses HL, Yang YY, Pietenpol JA. TGF-β stimulation and inhibition of proliferation: new mechanistic insights. Cell 1992;69:1067-70.
5. Clurman BE, Roberts JM. Cell cycle and cancer. J Natl Cancer Inst 1995;87:1499-1501.
6. Elbendary A, Berchuck A, Davis P, Havrilesky L, Bast RC Jr., Iglehart JD, et al. Transforming growth factor β1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Cell Growth Differ 1995; 5:1301-7.
7. Cantely L, Auger K, Carpenter C, Duckwortt B, Garziani A, Kapeller R, et al. Oncogenes and signal transduction. Cell 1991;64:281-302.
8. Lie CY, Suardet L, Little JB. Potential role of WAF1/Cip1/p21 as mediator of TGF-β cytoinhibitory effect. J Biol Chem 1995;270:4971-4.
9. KIP1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Devel 1994;8:9-22.
10. Kipl in C3H 10T1/2 mouse fibroblasts. Cancer Res 1995;55:1413-6.
11. Berchuck A, Rodriguez GC, Olt GJ, Boente MP, Whitaker RS, Arrick B, et al. Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-β. Am J Obstet Gynecol 1992;166:676-84.
12. Hurteau JA, Rodriguez GC, Whitaker RS, Shah S, Mills GB, Bast RC, et al. Transforming growth factor-beta inhibits proliferation of human ovarian cancer cells obtained from ascites. Cancer 1994;74:93-9.
13. Creasman WT. New gynecologic cancer staging. Gynecol Oncol 1995;58:157.
14. Hirte HW, Clark DA, Mazurka J, O'Connell G, Rusthoven J. A rapid and simple method for the purification of tumor cells from ascitic fluid of ovarian carcinoma. Gynecol Oncol 1992;44:223-6.
15. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Ann Biochem 1987;162:156-9.
16. Jacobs IJ, Kohler M, Wiseman R, Marks J, Whitaker R, Kerns BJ, et al. Clonal origin of epithelial ovarian cancer: analysis by loss of heterozygosity, p53 mutation and X-chromosome inactivation. J Natl Cancer Inst 1992;84:1793-4.
17. Daniels AM, McPherson JM, Daniels JR, Piez KA. Unusual antiproliferative effects of transforming growth factors β1 and β2 against primary cells from human tumors. Biotherapy 1989;1:133-7.
18. Tessier N, Hoang T. Transforming growth factor-β inhibits the proliferation of the blast cells of acute myeloblastic leukemia. Blood 1988;72:159-64.
19. Sing GK, Keller JR, Ellingsworth LR, Ruscetti FW. Transforming growth factor-β selectively inhibits normal and leukemic human bone marrow cell growth in vitro. Blood 1988;72: 1504-11.
20. Edwards DR, Murphy G, Reynolds JJ, Whitham SE, Docherty AJP, Angel P, et al. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 1987;6:1899-1905.
21. Laiho M, Saksela O, Andreasen PA, Keski-Oja J. Transforming growth factor β alters plasminogen activator activity in human skin fibroblasts. J Cell Biol 1986;103:2403-9.
22. Rodriguez GC, Berchuck A, Whitaker R, Stack M, Soper JT, Clarke-Pearson DL, et al. Regulation of invasion in ovarian cancer cell lines by transforming growth factor beta [abstract]. Gynecol Oncol 1995;56:137.